File #: 15-00192    Version: 1
Type: Agenda Item Status: Passed
File created: In control: BOARD OF SUPERVISORS
On agenda: 3/3/2015 Final action: 3/3/2015
Title: Consider recommendations regarding an amendment to the 340B Pharmacy Services Agreement with AmerisourceBergen Drug Company, as follows: a) Approve and authorize the Chair to execute the Fourth Amendment to the AmerisourceBergen Drug Company Prime Vendor Agreement to supply reimbursement for 340B medications dispensed to eligible County patients at participating 340B retail pharmacies including Walgreens Company. This Agreement will terminate on June 30, 2015; and b) Determine that these activities are exempt from California Environmental Quality Act (CEQA) review per CEQA Guideline Section 15378(b)(4), since this is a government fiscal activity that does not involve commitment to a specific project that may result in a potentially significant physical impact on the environment.
Sponsors: PUBLIC HEALTH DEPARTMENT
Attachments: 1. Board Letter, 2. Fourth Amendment AmerisourceBergen, 3. Purchasing Agreement AmerisourceBergen, 4. Second Amendment AmerisourceBergen, 5. Board Letter - Walgreens 1-13-15
Title
Consider recommendations regarding an amendment to the 340B Pharmacy Services Agreement with AmerisourceBergen Drug Company, as follows:
 
a) Approve and authorize the Chair to execute the Fourth Amendment to the AmerisourceBergen Drug Company Prime Vendor Agreement to supply reimbursement for 340B medications dispensed to eligible County patients at participating 340B retail pharmacies including Walgreens Company.  This Agreement will terminate on June 30, 2015; and
 
b) Determine that these activities are exempt from California Environmental Quality Act (CEQA) review per CEQA Guideline Section 15378(b)(4), since this is a government fiscal activity that does not involve commitment to a specific project that may result in a potentially significant physical impact on the environment.